Wound Management Products

 DISCLAIMER: Tissue allografts are regulated by the FDA solely under the authority of section 361, 21 CFR 1271.10(a) of the Public Health Service (PHS) Act — not as drugs, biologics, or medical devices. HCT/P 361 Allografts are not intended to treat or cure disease. Homologous Use Only applications apply. We market wound management products to Licensed Medical Professionals who care for patients with chronic or non-healing wounds. The information on this website is not meant to substitute for professional medical advice. To learn more about these allografts, schedule a meeting with LAB Medical Solutions or contact the manufacturer for IFU and usage applications.